Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dipeptidyl-peptidase 6 is an auxiliary subunit of Kv4-mediated A-type K(+) channels that, in addition to enhancing channel surface expression, potently accelerates their kinetics. The
dipeptidyl-peptidase 6
gene has been associated with a number of human central nervous system disorders including
autism
spectrum disorders and schizophrenia. Here we employ knockdown and genetic deletion of
dipeptidyl-peptidase 6
to reveal its importance for the formation and stability of dendritic filopodia during early neuronal development. We find that the hippocampal neurons lacking
dipeptidyl-peptidase 6
show a sparser dendritic branching pattern along with fewer spines throughout development and into adulthood. In electrophysiological and imaging experiments, we show that these deficits lead to fewer functional synapses and occur independently of the potassium channel subunit Kv4.2. We report that
dipeptidyl-peptidase 6
interacts with a filopodia-associated myosin as well as with fibronectin in the extracellular matrix.
dipeptidyl-peptidase 6
therefore has an unexpected but important role in cell adhesion and motility, impacting the hippocampal synaptic development and function.
...
PMID:DPP6 regulation of dendritic morphogenesis impacts hippocampal synaptic development. 2391 28